Diabetes impairs the atrial natriuretic peptide relaxant action mediated by potassium channels and prostacyclin in the rabbit renal artery.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Miranda I
Grupos
Abstract
Diabetes is associated with increased prevalence of hypertension, cardiovascular and renal disease. Atrial natriuretic peptide (ANP) plays an important role in cardiovascular pathophysiology and is claimed to have cardioprotective and renoprotective effect in diabetic patients. The working hypothesis was that alloxan-induced diabetes might modify the vascular effects of ANP in isolated rabbit renal arteries and the mechanisms involved in such actions. Plasma ANP levels were higher in diabetic rabbits than in control rabbits. ANP (10(-12)-10(-7)M) induced a relaxation of precontracted renal arteries, which was lower in diabetic than in control rabbits. In arteries from both groups of animals, endothelium removal decreased the ANP-induced relaxation but inhibition of NO-synthesis did not modify ANP-induced relaxations. In KCl-depolarised arteries, relaxation to ANP was almost abolished both in control and diabetic rabbits. Tetraethylammonium (TEA) partly inhibited the relaxation to ANP in control rabbits but did not modify it in diabetic rabbits. Glibenclamide and 4-aminopyridine inhibited the relaxation to ANP, and these inhibitions were lower in diabetic than in control rabbits. Indomethacin potentiated the relaxation to ANP, more in control than in diabetic rabbits. In the presence of ANP the renal artery released thromboxane A(2) and prostacyclin, and the release of prostacyclin resulted decreased in diabetic rabbits. The present results suggest that diabetes produces hyporeactivity of the rabbit renal artery to ANP by mechanisms that at least include the reduced modulation by prostacyclin and a lower participation of ATP-sensitive K(+) channel (K(ATP)), voltage-sensitive K(+) channels (K(V)) and TEA-sensitive K(+) channels (K(Ca)).
Datos de la publicación
- ISSN/ISSNe:
- 1043-6618, 1096-1186
- Tipo:
- Article
- Páginas:
- 392-400
- Factor de Impacto:
- 1,493 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
PHARMACOLOGICAL RESEARCH Elsevier Inc.
Citas Recibidas en Web of Science: 6
Documentos
- No hay documentos
Filiaciones
Proyectos asociados
INVESTIGACION EN RED DE LAS ENFERMEDADES NEUROLOGICAS
Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA
C03/06 . INSTITUTO DE SALUD CARLOS III . 2003
RED DE INVESTIGACION (RENEVAS)
Investigador Principal: ENRIQUE ALBORCH DOMÍNGUEZ
RD06/0026/0006 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA (FIDIS); FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006
RED DE INNOVACION EN TECNOLOGIAS MEDICAS Y SANITARIAS - RED ITEMAS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
RD09/0077/00156 . INSTITUTO DE SALUD CARLOS III . 2010
MICROCLUSTERS-CALIDAD, SEGURIDAD Y FUNCIONALIDAD DE ALIMENTOS
Investigador Principal: JOSÉ LUIS MULLOR SANJOSÉ
2011_0171_VLC/CAMPUS_MCI_MULLOR_SALOM . 2011
Cita
Marrachelli VG,Centeno JM,Miranda I,Castelló M,Burguete MC,Jover T,Salom JB,Torregrosa G,Miranda FJ,Alborch E. Diabetes impairs the atrial natriuretic peptide relaxant action mediated by potassium channels and prostacyclin in the rabbit renal artery. Pharmacol Res. 2012. 66. (5):p. 392-400. IF:4,346. (1).